| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
9e-08 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
4e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
5e-06 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |